Clinical nuclear medicine
Safety and Feasibility of [177Lu] Lu-PSMA Therapy in Glioblastoma.
Tahereh Ghaedian, Abdolmajid Alipour, Abbas Rakhsha, Hamid Nasrollahi, Mehrnaz Ghaedian, Babak Yazdani, Mohammad Atefi, Zahra Shabani, Nahid Masoudi
Published: 202610.1097/RLU.0000000000006219
Abstract
BACKGROUND: Glioblastoma (GBM) is the most common primary malignant tumor of the brain with high morbidity and mortality without an effective therapeutic option currently. This study aimed to evaluate the feasibility and safety of [177Lu] Lu-prostate…
Preview only. Read the full abstract at the source